Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
2078-54-8
Molecular formula
C12H18O
Molecular weight
178.2707 g/mol
Drug class
Intravenous general anaestheticSedative-hypnotic
Mechanism of action
The mechanism is not fully understood; propofol is thought to produce anaesthetic and sedative effects by positively modulating inhibitory GABA activity at ligand-gated GABA-A receptors.
Indications / reported uses
Induction of general anaesthesia
Maintenance of general anaesthesia
Monitored anaesthesia care sedation in adults
Sedation in adults receiving regional anaesthesia
ICU sedation of intubated, mechanically ventilated adults
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Propofol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Propofol Permitted Daily Exposure (PDE) report (the Propofol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Propofol Occupational Exposure Limit (OEL) report (the Propofol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.